Pfizer, the Viagra manufacturer, reports a very healthy growth in net income for 2009. They are showing a 7% increase to $8.6bn. This was helped considerably by the acquisition of Wyeth which helped push fourth quarter sales up by 34% to $16.6bn. Pfizer's predictions for 2010 are fairly modest but positive. These are good figures in hard times. |